Table 4.
Prevalence and levels of B19V DNA in plasma derivatives
| Time period | Product | Positive lots/lots tested(%) |
B19V DNA (geq/mL)among positive lots |
|||
|---|---|---|---|---|---|---|
| ≥ 104 | ≥ 103 | ≥ 102 | Log geq ± SEM | |||
| 1993–1995 |
albumin |
3/10 (30%) |
0 |
2 |
1 |
3.24 ± 0.44 |
| IVIG |
10/155 (6.5%) |
8 |
2 |
0 |
4.92 ± 1.13 |
|
| 2009–2011 |
albumin |
0/50 (0) |
0 |
0 |
0 |
/ |
| IVIG |
21/54 (38.9%) |
3 |
3 |
15 |
2.98 ± 0.65 |
|
| factor VIII |
19/35 (54.3%) |
6 |
9 |
4 |
3.76 ± 0.94 |
|
| Fibrinogen |
6/7 (85.7%) |
3 |
3 |
0 |
4.35 ± 1.26 |
|
| PCC |
12/17 (53.0%) |
4 |
4 |
4 |
3.54 ± 1.13 |
|
| Total | 71/328 (21.6%) | 24 | 23 | 24 | ||
SEM standard error of log geomean.